Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican‐American Population of South Texas

Suet‐Ying Kwan(The University of Texas MD Anderson Cancer Center), Laura Beretta(The University of Texas MD Anderson Cancer Center), Susan P. Fisher‐Hoch(The University of Texas Health Science Center), Joseph B. McCormick(The University of Texas Health Science Center at Houston), Jingjing Jiao(Second Affiliated Hospital of Zhejiang University), Peng Wei(Creighton University), Ying Wang(Affiliated Hospital of Hangzhou Normal University), Jonathan Qi(The University of Texas MD Anderson Cancer Center)
Hepatology Communications
March 19, 2020
10.1002/hep4.1490
Cited by 45

Related Papers

Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
|The Lancet|2015|518
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
|˜The œLancet. Gastroenterology & hepatology|2022|255
Gut commensal <i>Parabacteroides distasonis</i> alleviates inflammatory arthritis
|Gut|2023|237
Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases
|American Journal of Epidemiology|2017|218